Sekhmet Pharmaventures In The News
A selection of latest news about the Sekhmet Pharmaventures platform
August 28, 2024
Optimus Annual ESG Databook
August 8, 2024
Anjan Drug Annual ESG Databook
March 16, 2024
Sustainability Report FY 22 -23
March 5, 2024
Annual Returns 2022 – 2023
Sekhmet Pharmaventures
Sekhmet Pharmaventures Pvt. Ltd. (part of Gamot API Pte Ltd. based in Singapore) was formed by Asian private equity major PAG, along with Indian private equity firms, CX Partners and Samara Capital. The three has formed an investment platform called Gamot API Pte. Ltd. based in Singapore, with the aim to buy stakes in fast-growing pharma companies. Sekhmet Pharmaventures continues to combine inorganic endeavors together with organic growth activities, in order to form a leading Pharma platform in the spaces of intermediates, API, Finished Dosage Formulations and CMO & CDMO services.